Author(s): Danial Dalloul, Lama Doya, Iyad Almahmoud, HaissamYazigi

Email(s): drdanialdalloul@gmail.com

DOI: 10.5958/0974-360X.2018.00164.6   

Address: Danial Dalloul1*, Lama Doya1, Iyad Almahmoud2, HaissamYazigi3
1Postgraduate Student in Laboratory Diagnosis Department, Faculty of Medicine, Tishreen University, Latakia-Syria
2Doctor at Laboratory Diagnosis Department, Faculty of Medicine, Tishreen University, Latakia-Syria
3Professor at Laboratory Diagnosis Department, Faculty of Medicine, Tishreen University, Latakia-Syria
*Corresponding Author

Published In:   Volume - 11,      Issue - 3,     Year - 2018


ABSTRACT:
Background: Acinetobacter species are ubiquitous in the environment, and have emerged as important nosocomial pathogens. They are resistant to many antibiotic groups, especially beta lactams which is the most clinically-important group. However, There is a poor knowledge about Acinetobacter susceptibility profile in Syria. Aim of the study: To detect distribution of Acinetobacter in different sections of involved hospital and its susceptibility profile to beta-lactams. Material and methods: 88 Acinetobacter samples obtained through 24 months from different departments of Al-Assad University Hospital, Latakia- Syria. Species was identified using api 20E and api 20NE (bioMérieux-France) and susceptibility profile for beta-lactams was detected using E-Test (bioMérieux-France) Results: The prevalence of Acinetobacter has reduced from 3.74% in the first year (2015) to 3.06% in the second year (2016), but the resistance to antibiotics used in the study has increased( except Azetreonam). The resistance rates were 11.4% for Ampicillin-Sulbactam, 78.4% for Ticarcillin-Clavulanic acid, 90.9% for Cefotaxime, 43.2% for Cefepime, 48.9% for Imipenem, 40.9% for Meropenem, and 44.3% for Azetreonam. Conclusion: Acinetobacter develops resistance for beta-lactams rapidly. Ampicillin-Sulbactam is the drug of choice for Acinetobacter infections in Syria.


Cite this article:
Danial Dalloul, Lama Doya, Iyad Almahmoud, HaissamYazigi. The Prevalence of Acinetobacter in hospitals and its resistance to Beta-lactams. Research J. Pharm. and Tech. 2018; 11(3): 889-893. doi: 10.5958/0974-360X.2018.00164.6


Recomonded Articles:

Author(s): Amurdhavani. B.S

DOI: 10.5958/0974-360X.2016.00299.7         Access: Closed Access Read More

Author(s): Nada Khazal Kadhim Hindi, Iman Fadhil Abdul-Husin, Zainab Khudhur Ahmad Al-Mahdi, Ruqaya M. J. Ewadh, Ahmed Obaid Hossain, Mohanad Jawad Kadhim, Ali Hussein F. Alnasraui, Amean A. Al-Yaseri

DOI: 10.5958/0974-360X.2017.00343.2         Access: Open Access Read More

Author(s): A. Kaura, Lalit Sharma, V. J. Dhar

DOI: Not Available         Access: Open Access Read More

Author(s): Hisham A. Abbas, Mona A. El-Sayed, Laila M. Al-Kadi, Amany I. Gad

DOI: Not Available         Access: Open Access Read More

Author(s): Chinedu Fredrick Anowi, Nnabuife Chinedu Cardinal, A.F. Onyegbule, L.N. Anowi

DOI: Not Available         Access: Open Access Read More

Author(s): Saurabh Bharadwaj, U.V.S. Teotia, Kishan Singh, Rajib Sharma, Yogendra Singh

DOI: Not Available         Access: Open Access Read More

Author(s): Roushan Mubarak, Shaden Haddad, Outhman Hamdan

DOI: 10.5958/0974-360X.2016.00022.6         Access: Open Access Read More

Author(s): Gitasri Chakraborty, A. Kumaresan, Kiruthika. S Manoj Abraham

DOI: 10.5958/0974-360X.2018.00030.6         Access: Open Access Read More

Author(s): S. Syed Shihaab E Noor, Gopinath P

DOI: 10.5958/0974-360X.2018.00088.4         Access: Open Access Read More

Author(s): Chakravarthi V., Meera R., Arunachalam R., Sujatha B., M. Manoj Abraham

DOI: 10.5958/0974-360X.2019.00188.4         Access: Closed Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags